Kingsview Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,806
| Closed | -$457K | – | 1165 |
|
|
2024
Q3 | $457K | Sell |
4,806
-60
| -1% | -$5.7K | 0.01% | 753 |
|
|
2024
Q2 | $445K | Sell |
4,866
-25,328
| -84% | -$2.32M | 0.01% | 721 |
|
|
2024
Q1 | $2.74M | Buy |
30,194
+27,687
| +1,104% | +$2.51M | 0.07% | 261 |
|
|
2023
Q4 | $204K | Sell |
2,507
-530
| -17% | -$43.1K | 0.01% | 902 |
|
|
2023
Q3 | $243K | Hold |
3,037
| – | – | 0.01% | 826 |
|
|
2023
Q2 | $239K | Hold |
3,037
| – | – | 0.01% | 812 |
|
|
2023
Q1 | $236K | Hold |
3,037
| – | – | 0.01% | 787 |
|
|
2022
Q4 | $236K | Hold |
3,037
| – | – | 0.01% | 743 |
|
|
2022
Q3 | $204K | Hold |
3,037
| – | – | 0.01% | 757 |
|
|
2022
Q2 | $233K | Buy |
+3,037
| New | +$233K | 0.01% | 728 |
|